Key Highlights As House Dems Drop Hammer On Drugmakers

Law360 (October 5, 2020, 10:22 PM EDT) -- Newly released corporate documents unearthed by Democrats on the House Oversight Committee last week provide rare glimpses into how major drugmakers that earned billions of dollars from massive U.S. price increases made public defenses of price hikes that at times appeared inconsistent with their internal discussions.

Democrats on the committee released the documents — which consist largely of emails and internal presentations — during two days of hearings on "unsustainable drug prices," arguing that they contradict the pricing justifications often delivered to lawmakers and consumers.

Here, Law360 shares key highlights from the trove of internal documents from Teva Pharmaceutical Industries Ltd.,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!